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ttp://dx.doi.org/10.1016/j.jmoldx.2014.06.008We have developed novel probe systems for real-time PCR that provide higher speciﬁcity, greater sensitivity,
and lower cost relative to dual-labeled probes. The seven DNA Detection Switch (DDS)-probe systems
reported here employ two interacting polynucleotide components: a ﬂuorescently labeled probe and a
quencher antiprobe. High-ﬁdelity detection is achieved with three DDS designs: two internal probes
(internal DDS and Flip probes) and a primer probe (ZIPR probe), wherein each probe is combined with a
carefully engineered, slightly mismatched, error-checking antiprobe. The antiprobe blocks off-target
detection over a wide range of temperatures and facilitates multiplexing. Other designs (Universal probe,
Half-Universal probe, and MacMan probe) use generic components that enable low-cost detection. Finally,
single-molecule G-Force probes employ guanine-mediated ﬂuorescent quenching by forming a hairpin
between adjacent C-rich and G-rich sequences. Examples provided show how these probe technologies
discriminate drug-resistant Mycobacterium tuberculosis mutants, Escherichia coli O157:H7, oncogenic EGFR
deletion mutations, hepatitis B virus, inﬂuenza A/B strains, and single-nucleotide polymorphisms in the
human VKORC1 gene. (J Mol Diagn 2014, 16: 627e638; http://dx.doi.org/10.1016/j.jmoldx.2014.06.008)Supported by Small Business Innovative Research grants from the NIH
(1R43AI081511 and 1R43AI090852 to D.A.S./GeneTAG).
Disclosures: D.A.S. is the President, Founder, and principal shareholder
of GeneTAG Technology, Inc. P.H. is the Vice President and a shareholder
of GeneTAG Technology. J.L.M. is an employee of GeneTAG Technol-
ogy. These technologies are covered by US patent no. 8,076,067 and other
patents pending.Quantitative real-time PCR (qPCR) assays are typically
based on TaqMan or Molecular Beacon probes that mech-
anistically require ampliﬁcation of a target region using a
pair of ﬂanking primers, and ﬂuorescent detection of an
internal sequence with a dual-labeled probe, generally
having a 50 ﬂuorophore and a 30 quencher.1,2 The typical
cost of such probes is around US $150 to $250 per target,
due to the special costs of making and purifying dual-
labeled probes. Floating TaqMan probes are quenched in
the absence of targets due to random coiling in solution,
which allows their ﬂuor- and quencher-labeled ends to come
together. TaqMan ﬂuorescence occurs when the probe binds
to the target and the advancing Taq polymerase then cleaves
the ﬂuorophore from the probe.3 In contrast, Molecular
Beacon probes are designed with a set of 5 to 7 matching
bases on their 50 and 30 ends, which induce hairpin forma-
tion and stabilize the quenched state.2 Fluorescent detection
results when such probes hybridize with their targets and the
labeled ends are separated.stigative Pathology
.Although TaqMan and Molecular Beacon probes are
reliable for detecting matching target sequences, they can be
more difﬁcult to design and less effective when discrimi-
nating between closely related targets, especially single-
nucleotide polymorphisms (SNPs), drug-resistant mutants, or
somatic cancer mutations.4,5 In these situations, an effective
probe requires a careful balancing act based on melting
temperature (Tm) so that the probe correctly touches down
and positively detects a fully matching target at an optimized
annealing temperature, while at that same temperature, it
does not bind or detect similar targets differing by a single
base. Thus, repeated design and testing are commonly
Table 1 Sequences of Primers, Probes, and Antiprobes Used in This Study
Target organism Target gene Primer, probe, or antiprobe sequence
E. coli O157:H7 uidA Fwd: 50-CAGTCTGGATCGCGAAAACTG-30
Rev: 50-ACCAGACGTTGCCCACATAATT-30
TaqMan MGB P: 50-TET-ATTGAGCAGCGTTGG-MGB/NFQ-30
iDDS P: 50-FAM-CACCAACGCTGCTCAATTC-Phos-30
iDDS AP: 50-GAATTGAGCTGCGTTGGTG-BHQ1-30
Hepatitis B S Fwd: 50-GTGTCTGCGGCGTTTTATCA-30
Rev: 50-GACAAACGGGCAACATACCTT-30
MacMan P: 50-CAL Fluor Red 610-CCTCTKCATCCTGCTGCTATGCCTCATC-
CCCCTCCTTCTCTCC-30
MacMan AP: 50-GAþGAAþGGAþGGþGG-BHQ2-30
TaqMan P: 50-CAL Fluor Red 610-CCTCTKCATCCTGCTGCTATGCCTCATC-
BHQ2-30
Human EGFR
deletion mutant in
exon 19 (d-19)
Fwd. ZIPR P: 50-CAL Fluor Red 610-TCTGGATCCCAGAAGGTGAG-30
ZIPR AP: 50-CTCACCTTCTGGGTTCCAGA-BHQ2-30
Rev: 50-CGTAGGCTTCATCGAGGATT-30
iDDS P: 50-FAM-CAAGGAATTAAGAGAAGCAACATC-Phos-30
iDDS AP: 50-GATGTTGCCTCTCTTAATTCCTTG-BHQ1-30
Human VKORC1 Fwd. G-Force P: 50-FAM-CCCCTCCA-S18-AGGAGGGGGCCTCTGGGAAGTCA-
AGCAAG-30
Rev: 50-AAATGCTAGGATTATAGGCGTGA-30
Human VKORC1 SNP rs9923231C Fwd: 50-CCTCTGGGAAGTCAAGCAAG-30
Rev: 50-AAATGCTAGGATTATAGGCGTGA-30
iDDS P: 50-FAM-CGCACCCGGCCAATG-Phos-30
iDDS AP: 50-CATCGGCCGGGTGCG-BHQ1-30
Inﬂuenza A A/California/04/2009
HA1, target #1
Fwd: 50-GTAGTTCTGCTATATACATTTGCAACC-30
Rev LP: 50-GCTACGTAGACTAGACGTTCCCTATACATAATGTGTCTGCATTTG-30
UP: 50-FAM-CCCTATCGCTACGTAGACTAGACGTTC-30
UAP: 50-TAGTCTACGTAGCGATAGGG-BHQ1-30
A/California/4/2009
HA1, target #2
Fwd. HUP: 50-FAM-CGTAGACTAGACGTTCGTGAATCACTCTCCACAGCAAG-30
HUAP: 50-GAACGTCTAGTCTA-BHQ1-30
Rev: 50-GTAACACGTTCCATTGTCTGAAC-30
A/California/4/2009
HA1, target #3
Fwd: 50-GGCAATACTAGTAGTTCTGCTATAT-30
Rev. HUP: 50-Quasar 670-GCACGCTACGTACTAGGTAATGTGTCTGCAT-
TTGCGGT-30
HUAP: 50-CCTAGTACGTAGCGTGC-BHQ2-30
A/California/4/2009
HA1, target #4
Fwd: 50-GTGCTATAAACACCAGCCTYCCA-30
Rev: 50-CGGGATATTCCTTAATCCTGTRGC-30
TaqMan P: 50-FAM-CAGAATATACA-BHQ1-CCRGTCACAATTGGARAA-S3-30
A/California/4/2009
HA1, target #5
A/California/4/2009
HA1, target #6
Fwd: 50-ATTTAATATGGCTAGTTAAAAAAGGAAA-30
Rev. HUP: 50-HEX-CATAGGTACCCTACGGACTTCTTTCCCTTTATCATTAATG-30
HUAP: 50-GTAGGGTACCTATG-BHQ2-30
Fwd: 50-TTCGCAATGGAAAGAAATGC-30
Rev. HUP: 50-CAL Fluor Red 610-ACGCCTAAGAGTAGCAAGTTGTATTGCA-
ATCGTGG-30
HUAP: 50-CTACTCTTAGGCGT-BHQ2-30
Inﬂuenza A A/Fujian/411/02
HA3, target #1
HA3, target #2
HA3, target #3
HA3, target #4
Fwd LP: 50-GCTACGTAGACTAGACGTTCCCTTTTTGTTGAACGCAGCA-30
Rev: 50-CTAGTGACCTAAGGGAGGCATAATC-30
Fwd LP: 50-GCTACGTAGACTAGACGTTCTGGAAGCATTCCCAATGACA-30
Rev: 50-GTACATTYCGCATCCCTGTTG-30
Fwd: 50-AACTGACTCAGAAATGAACAAACTGT-30
Rev LP: 50-GCTACGTAGACTAGACGTTCTGAAACAACCATTGCCCATATC-30
Fwd: 50-GGTGTTGAGCTGAAGTCAGGA-30
Rev LP: 50-GCTACGTAGACTAGACGTTCGCAGGCCCACATGATGAAC-30
UP: 50-FAM-CCCTATCGCTACGTAGACTAGACGTTC-30
UAP: 50-TAGTCTACGTAGCGATAGGG-BHQ1-30
(table continues)
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Table 1 (continued )
Target organism Target gene Primer, probe, or antiprobe sequence
Inﬂuenza A A/Hong Kong/483/97
HA5, target #1
HA5, target #2
HA5, target #3
Fwd LP: 50-GCTACGTAGACTAGACGTTCTGCCGGAATGGTCTTACATAGTG-30
Rev: 50-CCCTGGGTAACAGAGGTCATTG-30
Fwd LP: 50-GCTACGTAGACTAGACGTTCGTATGCCATTCCACAACATACACC-30
Rev: 50-GTCGCAAGGACTAATCTGTTTGA-30
Fwd LP: 50-GCTACGTAGACTAGACGTTCGAGGAAATAAGTGGAGTAAAATTGGA-30
Rev: 50-CCATGATTGCCAGTGCTAGG-30
UP: 50-FAM-CCCTATCGCTACGTAGACTAGACGTTC-30
UAP: 50-TAGTCTACGTAGCGATAGGG-BHQ1-30
Inﬂuenza A A/New York/18/2009
M1
Fwd: 50-CTTCTAACCGAGGTCGAAACGTA-30
Rev. ZIPR P: 50-FAM-GCTTTGAGGGGGCCTGA-30
ZIPR AP: 50-TCAGCCCCCCTCAAAGC-BHQ1-30
Inﬂuenza A A/California/4/2009
NA3
Fwd: 50-TGTTAACATCAGCAACACCAACT-30
Rev. HUP: 50-CAL Fluor Red 610-CGTTAACGCCTAAGAGTAGCTAATTTCA-
CGGAAACCACTGA-30
HUAP: 50-CTACTCTTAGGCGTTAACG-BHQ2-30
Inﬂuenza B B/Ohio/01/05
NS1
Fwd. ZIPR P: 50-CAL Fluor Red 610-CCCAATTTGGTCAAGAGCAC-30
ZIPR AP: 50-GTGCTGATGACCAAATTGGG-BHQ2-30
Rev: 50-CTAATTGTCTCCCTCTTCTGGTGA-30
MTB 16S rRNA Fwd: 50-GGGATAAGCCTGGGAAACTG-30
Rev: 50-ACCCCACCAACAAGCTGATA-30
TaqMan P: 50-FAM-CATGTCTTGTGGTGGAAAGC-BHQ1-30
MTB 16S rRNA Fwd Flip AP: 50-BHQ1-AAGACATGCATCCCGTGGT-S9-GGGATAAGCCTGG-
GAAACTG-30
Flip P: 50-TAGGACCACGGGATGCATGTCTT-FAM-30
Rev: 50-ACCCCACCAACAAGCTGATA-30
MTB inhA Fwd: 50-GCTCGTGGACATACCGATTT-30
Rev. G-Force P: 50-FAM-CCCCTCCA-S18-AGGAGGGGGTCCGGTAACCAGG-
ACTGAAC-30
iDDS P: 50-CAL Fluor Red 610-GGCGAGACGTTAGGTTATCGGGG-Phos-30
iDDS AP: 50-CCCCGACAACCTATCGTCTCGGC-BHQ2-30
MTB katG Fwd: 50-GGGCTGGAAGAGCTCGTAT-30
Rev: 50-GAGAAGCAGTCGAGGGTGAG-30
M1 iDDS P: 50-CAL Fluor Red 610-CGATCACCACCGGCA-Phos-30
M1 iDDS AP: 50-TGCCGGTGGTGACCG-BHQ2-30
M2 iDDS P: 50-CAL Fluor Red 610-CGCGATCACGAACGGCA-Phos-30
M2 iDDS AP: 50-TGACGTTGGTGATCGCG-BHQ2-30
Nucleotides in bold text reﬂect intentional mismatches in probes or antiprobes, where indicated and þ represents a locked nucleic acid after the “þ” sign.
AP, antiprobe; BHQ, Black Hole Quencher; HUAP, Half-Universal antiprobe; HUP, Half-Universal probe; iDDS, internal DNA Detection Switch; K, nonstandard
nucleotide, G or T; LP, linker primer; M1, katG mutant #1; M2, katG mutant #2; MGB, minor groove binder; NFQ, nonﬂuorescent quencher; P, probe; Phos, 30
phosphate group to block extension; R, nonstandard nucleotide, A or G; S3, 3-carbon spacer; S9, triethylene glycol spacer; S18, 18-atom hexa-ethyleneglycol
spacer; UAP, Universal antiprobe; UP, Universal probe; Y, nonstandard nucleotide, C or T.
DDS Probes for Advanced qPCR Detectionneeded to develop an effective probe, and then consistent
temperature and hybridization conditions are essential for
accurate performance.
Here we present seven novel DNA Detection Switch (DDS)
probe systems that overcome the difﬁculties of single-base
discrimination with dual-labeled probes, or that deliver
versatile, low-cost solutions for qPCR. These seven systems
were invented by D.A.S. and are patented or patent pending in
the United States, Canada, Europe, and China. DDS probes
employ the interaction of two labeled polynucleotide compo-
nents, a probe, and an antiprobe, wherein the probe binds
preferentially to its intended target, turning on signaling, while
it dissociates from binding to a nearly complementary antiprobeThe Journal of Molecular Diagnostics - jmd.amjpathol.orgthat otherwise turns off signaling. Typically, the probe
component is 50 labeled with a ﬂuorescent compound, and the
antiprobe is 30 labeled with a quencher compound, although
such labeling can be reversed. This general signaling mecha-
nism is termed a DDS. To achieve high-speciﬁcity detection,
the DDS probe was designed to fully match the target sequence,
and the antiprobe is made complementary to the probe except
for a carefully placed nonterminal mismatch. The thermody-
namics of this design enable exacting target detection because
the closely competitive antiprobes that are provided in excess
will bind any free-ﬂoating probes, quenching their ﬂuo-
rophores, and thereby preventing incorrect or false-positive
detection. For targets in which single-base discrimination is not629
Murray et alessential, sensitive and inexpensive detection can be achieved
with other DDS probes that use generic components. The de-
signs of the seven DDS probe systems are described subse-
quently, along with representative applications.
Materials and Methods
Primer and Probe Synthesis
Primers and labeled DDS probe components were synthesized
by Biosearch Technologies, Inc. (Petaluma, CA) or Integrated
DNA Technologies, Inc. (Coralville, IA). Ultramer templates
(approximately 120 bases long) were synthesized by
Integrated DNA Technologies. Probes were labeled with 5-
carboxyﬂuorescein (FAM), 6-carboxy-20,4,40,50,7,70-hexa-
chloroﬂuorescein (HEX), CAL Fluor Red 610 [an equivalent
of carboxy-X-rhodamine (ROX)], or Quasar 670 (Cy5
equivalent), and antiprobes were labeled with Black Hole
Quencher 1 or 2. With regard to the design of each probe,
antiprobe pairing was facilitated by sequence analysis and
simulated hybridization testing using the online NUPACK
(version 3.0.4, California Institute of Technology, Pasadena,
CA) and DINAMelt Web Server (UNAFold version 3.9,
Rensselaer Polytechnic Institute, State University of NY at
Albany, Troy, NY) programs.6,7 Customized TaqMan assays
were obtained through Applied Biosystems (Carlsbad, CA).
Primer, probe, and antiprobe sequences are listed in Table 1.Figure 1 The iDDS probe system. A and B: iDDS probe/antiprobe design favor
the antiprobe, and iii) a mismatched target. The ﬂuorophore and quencher are ind
minimizes background ﬂuorescence to increase the signal/noise ratio.9e11 C: Pred
the M1 target, an antiprobe, an alternate mutant (M2), and WT katG. These Tm l
discrimination with iDDS probes for two MTB katG mutants.
630Real-Time PCR Studies
For qPCR testing, we typically used the following condi-
tions: 200 nmol/L of the ﬂuorescent probe, 400 nmol/L of
the quencher-labeled antiprobe, and 200 nmol/L of any other
primer(s). In Universal probe assays, the concentration of
linker primer used in the ﬁrst-step reaction was 20 nmol/L,
and Universal probe and antiprobe concentrations were 200
and 400 nmol/L, respectively. We typically used 10 ng of
viral cDNA or 1000 to 10,000 copies of ultramer template
per reaction. qPCR reactions were performed in 25-mL
volumes containing 12.5 mL of 2X HotStart-IT Probe qPCR
Master Mix (Affymetrix, Inc., Santa Clara, CA), the indi-
cated template, primer, probe, and/or antiprobe concentra-
tions, and additional MgCl2 and dNTPs (added at ﬁnal
concentrations of 5 and 0.1 mmol/L, respectively). Typical
thermal cycling conditions are 95C, 5 minutes, and then 40
cycles of either two-step PCR (denaturation at 95C for 15
seconds, and annealing/extension at 58C for 30 to 60 sec-
onds), or three-step PCR (denaturation at 95C, 15 seconds;
annealing at 58C, 45 seconds; and extension at 72C, 45
seconds).
Test Sample Acquisition
Viral RNA from inﬂuenza A strains A/Hong Kong/483/97, A/
Vietnam/1203/04, A/Vietnam/Hanoi/30408/05, A/California/s probe binding to (in order of decreasing afﬁnity): i) the correct target, ii)
icated with white and black circles, respectively. Fluor-quencher alignment
icted thermodynamics6,7 of an MTB katG mutant 1 (M1) probe hybridizing to
evels run high relative to other common on-line programs. D: Single-base
jmd.amjpathol.org - The Journal of Molecular Diagnostics
DDS Probes for Advanced qPCR Detection04/2009, A/Solomon Islands/03/2006, and A/New York/18/
2009 were gifts from Dr. Ruben Donis [Centers for Disease
Control and Prevention (CDC), Atlanta, GA]. RNA from
inﬂuenza B/Ohio/01/05 was a gift from Dr. Mark Tompkins
(University of Georgia, Athens, GA). Viral RNA was reverse-
transcribed using random hexamers and the High-Capacity
cDNA Reverse Transcription Kit (purchased from Applied
Biosystems). Escherichia coli samples were gifts from Dr.
Michael Vickery (BioGX, Birmingham, AL). Samples of lung
cancer DNAwith known EGFRmutations were gifts fromDrs.
Charles E. Hill and Michael Rossi (Emory University, Atlanta,
GA) and Dr. Mark Bouzyk (AKESOgen, Inc., Norcross, GA).
Various Mycobacterium tuberculosis (MTB) samples were
gifts from Drs. Thomas Shinnick, Wenming Zhu, and James
Posey (CDC). A plasmid encoding the full-length HIV-1Figure 2 Performance of iDDS and TaqMan MGB probes in detecting a diagno
Each graph depicts ampliﬁcation plots with the mutant E. coli template, the WT E
qPCR varying from 63C to 40C. The TaqMan minor groove binder (MGB) probe sh
the annealing temperature decreases, and ﬁnally shows false-positives with a wate
the pathogenic E. coli SNP variant at all annealing temperatures from 63C to 40
The Journal of Molecular Diagnostics - jmd.amjpathol.orgNL4-3 molecular clone was obtained at no charge from the
AIDS Research and Reference Reagent Program, Division of
AIDS, National Institute of Allergy and Infectious Diseases,
National Institutes of Health (Rockville, MD), from Dr.
Malcolm Martin.8 Hepatitis B DNA derived from hepatitis
Bþ human serum or plasma samples was purchased from BBI
Diagnostics Inc. (Bridgewater, MA). Synthetic ultramers were
used for the MTB and EGFR studies discussed.
Results
Internal Probes: iDDS, MacMan, and Flip Probes
The DDS probe systems described here consist of three in-
ternal probe systems [internal DDS (iDDS), MacMan, andstic SNP mutant of O157:H7 E. coli as a function of annealing temperature.
. coli template, and a water control, with the annealing temperature during
ows increasingly obvious false-positive (FP) curves with the WT template as
r control. The iDDS probe demonstrates effective and exclusive detection of
C.
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Murray et alFlip] and four primereprobe systems (ZIPR, Universal, Half-
Universal, and G-Force). Each system will be described
sequentially.
The iDDS probe system comprises two equal-length oli-
gonucleotides that interact together: a 50 ﬂuor-labeled probe
that is complementary to the target sequence, and a 30
quencher-labeled antiprobe that is complementary to the
probe except for an intentionally mismatched base (Figure 1,
A and B). The 30 end of the probe is blocked to prevent
extension. The target site for the probe is internal to a pair of
ﬂanking primers. The iDDS probe structure imparts three
distinct levels of thermodynamic binding afﬁnity during the
transition from denaturation to annealing: level 1, strong
binding [high Tm and low Gibbs free energy (DG)] between
the probe and a matching target; level 2, intermediate binding
between the probe and antiprobe; and level 3, low binding
between the probe and a mismatched target differing by a
single base. To work effectively, the probe sequence and the
position and type of antiprobe mismatch are carefully engi-
neered to achieve Tm andDG differentials of about 5.2C and
about 2.3 kcal/mol, respectively, between each of the three
thermodynamic binding levels. The antiprobe therefore
provides both a signaling switch and a unique error-checking
function that blocks probe binding to incorrect targets even
when annealing temperatures are suboptimal. As a result,
iDDS probes achieve and maintain single-base discrimina-
tion over a wide temperature range. Figure 1B illustrates how
the hybridization/annealing step window can shift up or
down and still maintain the three afﬁnity levels described
earlier such that, during qPCR, the probe binds ﬁrst to the
correct target and then to the antiprobe, and does not bind to
an incorrect target at essentially any annealing temperature.
Figure 1, C and D illustrates these thermodynamic relation-
ships and the results thereof, with an iDDS probe and
antiprobe that detect a point mutation in the MTB catalase-
peroxidase gene (katG, which confers isoniazid drug resis-
tance)12,13 and that discriminate between that mutation and
an alternate resistance mutation and the wild-type (WT)
sequence. Note the Tm and DG differentials between probe-
to-target binding, probeeto-antiprobe binding, and probe
binding to the incorrect target.Figure 3 MacMan probes. A: In the absence of target, free-ﬂoating MacMan p
detection occurs during qPCR as the MacMan probe anneals to the template, separa
of hepatitis B virus DNA (BBI Diagnostics) versus two negative controls (HIV-1 pN
the hepatitis S gene with MacMan versus TaqMan probes for the same target seq
632Next, we studied the wide temperature range over which
iDDS probes can deliver single-base discrimination. Figure 2
provides an example of this performance by comparing an
iDDS probe targeting theþ93 SNP in the uidA gene of highly
pathogenic E. coli O157:H7 to the performance of a TaqMan
minor groove binder (MGB) probe, designed and recom-
mended by the US Food and Drug Administration (FDA),14
which targets the same SNP variant. (MGB is an expensive
molecular enhancement that enables shorter and more base-
speciﬁc probes.) The þ93 SNP is highly conserved in
O157:H7 and O157:He strains that produce Shiga toxins, and
serves as an accurate identiﬁcation marker for these severe
pathogens.15 Note that the iDDS probe was designed to run at
an annealing temperature of 58C, whereas the TaqManMGB
probe was designed for a 63C annealing step. Using the
concentrations and PCR conditions recommended by the FDA
for the TaqMan MGB probe for O157-H7 E. coli,14 we tested
both probes over a series of annealing temperatures ranging
from 63C to 40C. Note that as the annealing temperature
decreases, the TaqManMGB probe shows a steady increase in
false-positive curves with the nonpathogenic E. coli template
and eventually evenwith a water control. In contrast, the iDDS
probe provides consistent single-base speciﬁcity using the
same templates and annealing temperatures, making iDDS
probes suitable for multiplexing the detection of two or more
targets that require single-base discrimination. This capacity is
generally not possible with the TaqMan MGB probes.16
MacMan probes are constructed with a ﬂuor-labeled probe
segment and a generic tail that recruits a matching generic
antiprobe with quencher labeling (Figure 3A). The generic
sequences lack signiﬁcant homology with known genomes.
During ampliﬁcation, the probeeantiprobe complex hybrid-
izes to the target region, separating the labeled ends and
generating a ﬂuorescent signal. Otherwise, the probe randomly
coils, bringing the labeled ends together and turning off
detection. Thus, MacMan and TaqMan probe detection occurs
via similar mechanisms, although MacMan assays offer a cost
advantage because the same generic antiprobe can be used
with multiple target-speciﬁc probes. AMacMan probe speciﬁc
for the hepatitis B S gene did not detect unrelated HIV-1 or
MTB templates (Figure 3B) and showed detection similar torobes are quenched by generic antiprobes that bind generic 30 tails. Target
ting the probe from the quencher. B: MacMan probe detection of the S gene
L4-3 plasmid and an MTB ultramer template). C: Comparison of detection of
uence.
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Figure 4 Flip probes. A: In the quenched state, a Flip probe binds to a
quencher-labeled antiprobe segment that is joined to a primer. The probe
sequence (dashed line) is several bases longer than is the antiprobe
sequence. The 50 antiprobe sequence is structurally connected to the 30
primer sequence by an S9 spacer (triethylene glycol, black box). The spacer
prevents copying of the antiprobe sequence during qPCR. Numbering in the
diagram reﬂects: i) probe bound to antiprobe, ii) probe bound to target, iii)
primer linked to antiprobe, and iv) the second primer. B and C: Comparison
of the TaqMan and Flip probes in detecting the MTB 16S gene, using MTB
genomic DNA that was serially diluted from 107 to 104 copies per reaction.
Since TaqMan curves can variably converge at the end point, cycle threshold
values must be detected to determine target quantity. In contrast, Flip
probe curves are linear so that end point ﬂuorescence also reﬂects relative
target frequency. Linear regression analysis of the MTB samples tested in C
supports that end point ﬂuorescence at 40 cycles correlates with copy
number, and thus, quantitative end point detection may be achieved (D).
R2 Z 0.985, based on four curves per dilution in C.
DDS Probes for Advanced qPCR Detectionthat with a TaqMan assay against the same sequence
(Figure 3C).
The Flip probe system comprises two components: a 30
ﬂuor-labeled probe component and a 50 quencher-labeled
antiprobe component that is joined via an S9 spacer
(triethylene glycol) to a 30 primer sequence (Figure 4A). The
probe and antiprobe sequences are complementary, except the
50 end of Flip probes can bemade several bases longer than the
antiprobe to favor detection. The spacer prevents copying of
the antiprobe during PCR. During the annealing step, the
probe preferentially ﬂips forward and binds to the targeted
DNA sequence between the primer sites, thereby leaving the
antiprobe behind and releasing signaling. Although the Taq-
Man and Flip probes were both effective in detecting the 16S
gene of MTB (Figure 4, B and C), the behavior of one primer
was kinetically altered by the Flip probe system so that the
ampliﬁcation curves generated were linear rather than
sigmoidal in shape. Consequently, Flip probes enabled true
quantitative end point detection similar to the beneﬁt of linear-
afterethe-exponential PCR (Figure 4D).17 Note that the
ﬂuorescence levels at the end point are proportionate to the
cycle threshold values as well as to the starting copy number
(R2Z 0.985). Flip probes thus offer both high stringency and
end point detection in situations in which a qPCR instrument is
not available, such as in many point-of-care facilities.
Primer-Probes: ZIPR, Universal, Half-Universal, and
G-Force Probes
Our DDS primereprobe systems comprise ﬂuorescently tag-
ged primers that drive ampliﬁcation and that directly label all
amplicons for maximum ﬂuorescence. ZIPR primer-probes
have a probeeantiprobe structural design (Figure 5A) that is
almost the same as that of iDDS probes (Figure 1, A and B),
except that the 30 ends of ZIPR probes are not blocked and they
serve as primer probes, not as internal probes. With this design,
the antiprobe still improves speciﬁcity by inhibiting off-target
detection. Figure 5, B and C show ZIPR probes that distin-
guish homologous sites in the inﬂuenza A M1 gene or the
inﬂuenza B NS1 gene. ZIPR probes can also be combined with
iDDS probes for two-color detection of each amplicon
(Figure 5D). In such applications, the iDDS probe typically
targets a speciﬁc mutation of interest, whereas the ZIPR probe
serves as a reference to conﬁrm the presence and relative
quantity of the gene. This approach was used to determine the
presence or absence of variably sized deletion mutations that
commonly occur in codons 746 to 753 of exon 19 (d-19) of
EGFR in patients with non-small-cell lung carcinoma.18 Rather
than designingmultiple iDDS probes to detect all possible d-19
mutants, a simple one-tube assay was developed using a
ROX-labeled ZIPR probe and a FAM-labeled iDDS probe that
detects two sites in the same amplicon (Figure 5D). The
reference ZIPR probe detects all amplicons of EGFR equally,
whether WT or with a deletion mutation. However, the iDDS
probe only detects and signals whether the full WT sequence is
present at the deletion site. Therefore, WT templates provideThe Journal of Molecular Diagnostics - jmd.amjpathol.org 633
Figure 5 ZIPR probes. A: When ZIPR probes incorporate into PCR products, antiprobe binding is prevented and ﬂuorescence signaling is enabled. ZIPR
probes label all amplicons with high sensitivity, and antiprobe intervention favors on-target detection. Discriminating inﬂuenza strains using ZIPR probes
speciﬁc for inﬂuenza A/New York/18/2009 M1 (B) or inﬂuenza B/Ohio/01/05 NS1 (C) transcripts. D: Strategy for detecting EGFR d-19 mutants. The reference
ZIPR probe targets a conserved sequence upstream of the EGFR d-19 site, allowing it to detect both WT and deletion mutants with equal efﬁcacy. In contrast,
the FAM-labeled iDDS probe detects only the WT EGFR sequence, since all known d-19 mutations (9 to 24 base pairs) disrupt probe binding. Real-time PCR
curves observed with samples containing 100% WT template (E), 50%/50% WT/mutant template (F), or 100% mutant template (G). d-19 Mutant frequencies
are reﬂected by the angle of the FAM curve relative to the ROX-labeled reference curve.
Murray et altwo positive ROX/FAM curves (Figure 5E), whereas 100%
mutant templates provide only an amplicon-positive ROX
curve and a ﬂat FAM curve (Figure 5G). With this method, the
relative angle of the FAM curve to the ROX curve is propor-
tional to the frequency of d-19 mutants present in the sample
(Figure 5F).
Universal and HalfeUniversal-primer probes are further
variations of DDS technology involving generic probe and
antiprobe components. With Universal probes, detection
occurs in two stages (Figure 6A). In the ﬁrst cycle, a linker
primer is used to copy and extend the target region with a
generic sequence. In subsequent cycles, copies containing
the appended sequence serve as a target sequence for the
Universal primereprobe. The Universal probe takes over
ampliﬁcation quickly because the linker primer is pro-
vided at a lower concentration (20 versus 200 nmol/L).
Detection occurs when a Universal probe is incorporated
into an amplicon, separating the labeled probe from the
generic antiprobe. Because of their generic sequences,
Universal probes and antiprobes, prepared in bulk, may be
used to detect a new target or a series of targets at basically
the cost of the linker primers needed (<$10 each). This
strategy can be advantageous for screening multiple target
sites to develop an effective assay. Figure 6C shows a
Universal probe that discriminates the 2009 pandemic
inﬂuenza A H1N1 strain19 from the H1N1 strain in prior
circulation. Considering the mutability of viral genomes,
greater conﬁdence in molecular diagnostics can be ach-
ieved by detecting viral sequences at multiple sites to
reduce false-negatives and false-positives. This approach
was taken using a single Universal probeeantiprobe pair
to detect H3N2 and H5N1 inﬂuenza A strains at conserved634sites within their HA genes (Figure 6, B, D, and E).
Although some variation in amplitude was observed, cycle
threshold numbers were consistent, as would be expected
when detecting the same target species with multiple
probes.
In contrast to Universal probes, Half-Universal probes do
not use a linker primer and they initiate ampliﬁcation and
detection in one step. A Half-Universal probe is composed
of a generic tag sequence with a 50 label that is joined
directly to a 30 target-speciﬁc primer sequence (Figure 6F).
In the quenched state, a Half-Universal probe hybridizes
with a matching generic antiprobe, but ﬂuorescence is
liberated when Half-Universal probes are incorporated into
qPCR products. Figure 6G shows a Half-Universal probe
speciﬁc for the 2009 H1N1 pandemic ﬂu that discriminates
against older H1N1 and H5N1 strains, and showed earlier,
more robust detection compared with that of the ofﬁcial
TaqMan assay from the CDC’s real-time reverse-tran-
scription PCR swine ﬂu panel,20 which targets the same
sequence region (Figure 6H). The higher signal/noise ratio
of Half-Universal probes versus TaqMan probes reﬂects the
facts that all amplicons are labeled and that quenching is
more effective because ﬂuors and quenchers are stably
aligned. Figure 6I shows multiplex detection of an H1N1
inﬂuenza A RNA sample at three sites within the HA gene,
based on using three Half-Universal probes with different
ﬂuorophores and generic sequences. The presence of par-
allel but not identical curves supports target detection.
Similarly, two Half-Universal probes targeting the HA and
NA genes of the 2009 H1N1 pandemic ﬂu clearly distin-
guished between viral cDNA samples from the 2009 H1N1
strain and the older H1N1 strain (Figure 6J). The samejmd.amjpathol.org - The Journal of Molecular Diagnostics
Figure 6 Universal probes and Half-Universal probes. A: Universal probe assays involve two-step detection. The linker primer appends the amplicon with a
binding site for the Universal probe (red). The linker primer starts ampliﬁcation in the ﬁrst cycle, and then the Universal probe takes over and provides
signaling. Unincorporated probes are quenched by hybridization with antiprobes. The Universal probe is 7 bases longer than the antiprobe, favoring detection.
Schematic representation of an inﬂuenza A HA3 segment and four selected Universal probe sites (B), and their use in detecting H3N2 inﬂuenza A strain
A/Fujian/411/02 (D). C: Discriminating inﬂuenza A/California/04/2009 and A/Solomon Islands/03/2006, using viral cDNA and Universal probes. E: Multiplex
detection of H5N1 inﬂuenza A/Hong Kong/483/97 cDNA at three different HA5 sites with Universal probes. F: Fluorescent HalfeUniversal-primer probes
associate with antiprobes in the absence of target. Ampliﬁcation separates Half-Universal probes from antiprobes, releasing ﬂuorescence. G: A Half-Universal
probe targeting H1N1 inﬂuenza A/California/4/2009 cDNA discriminated between H1N1 (A/Solomon Islands/03/2006) and H5N1 (A/Hong Kong/483/97)
strains. H: Half-Universal probe-based detection of the inﬂuenza A/California/4/2009 HA gene compared with a TaqMan HA assay from the CDC real-time
reverse-transcription PCR swine ﬂu panel20. I: Multiplex assays with Half-Universal probes targeting the inﬂuenza A/California/4/2009 HA gene at three
sites. J: Multiplex discrimination of inﬂuenza A/California/4/2009 and A/Solomon Islands/03/2006 templates using Half-Universal probes. Parallel detection
of serially diluted A/California/4/2009 cDNA with the HA1 and NA3 Half-Universal probes discussed in J and K.
DDS Probes for Advanced qPCR Detectionprobes tested with serial dilutions of the target template
produced a series of parallel curves with almost identical
cycle threshold values, supporting true-positive detection
even with low-frequency templates (Figure 6K).
The G-Force probe system (Figure 7A) consists of a
multisegment oligonucleotide with a 50 ﬂuorescent label, a
C-rich segment, an S18 spacer (hexa-ethyleneglycol), a
G-rich segment, and a target-speciﬁc primer sequence.
When the probe is free-ﬂoating, the 8-base G-rich and C-richThe Journal of Molecular Diagnostics - jmd.amjpathol.orgsegments fold together, bringing several Gs near the ﬂuo-
rescent label. The proximal G bases absorb ﬂuorescence by
photo-induced electron transfer,21e23 and thus, the G-rich
segment serves as an antiprobe. No quencher is required. As
the probe is incorporated into an amplicon, the G-rich
segment is copied, folding is prevented, and ﬂuorescent
signaling is released. Figure 7, BeD show applications of
G-Force probes as low-cost reference probes for detecting an
SNP in the human VKORC1 gene (rs9923231) related to635
Murray et alwarfarin dosing24 and the major mutant site of inhA that
confers isoniazid drug resistance in MTB.25 The G-Force
probe labels the amplicon one color (eg, FAM) irrespective
of any WT or mutant sequence between the primers. The
iDDS probe selectively detects a mutant or WT sequence
using another color (eg, ROX), and the proportion of mu-
tants present will change the angle and amplitude of the
iDDS signaling curve, thereby providing a visual index of
the mutant frequency.Figure 7 G-Force probes. A: G-Force probes consist of complementary
C- and G-rich regions that self-hybridize in the quenched state to juxtapose the
ﬂuorophore and the G-rich region, or separate during ampliﬁcation to activate
detection. B: A ﬂanking G-Force probe targeting a conserved site in the human
VKORC1 gene shows comparable detection of ultramer templates encoding the
WT and SNP variant rs9923231C. C: iDDS probe detection of the WT VKORC1
template, using mixed WT and SNP variant templates ranging from 100% to 0%
WT. D: Multiplex detection of the WT MTB inhA gene with mixed WT/mutant
templates. qPCR was performed using a reference G-Force probe and an iDDS
probe targeting theWT sequence at a site that confers isoniazid resistance when
mutated. With the 75% WT sample, the iDDS signaling curve drops about 25%
relative to the G-Force curve, and with the 25%WT sample, the iDDS curve drops
another 50% relative to the G-Force curve, providing semiquantitative mutant
frequency analysis. w/m, WT/mutant.Discussion
DDS probes provide effective single-base discrimination,
enhanced signaling, andmultiplexing. The generic components
also enable reduced costs. Three probe systems in particular
(iDDS, ZIPR, and Flip) provide high speciﬁcity relative to
conventional probes (TaqMan, Molecular Beacon) due to the
precise and effective role of the antiprobe in blocking off-target
detection. The iDDS probe of Figure 2 demonstrates this ca-
pacity relative to the FDA-approved TaqMan MGB probe for
the same SNP target. The TaqMan MGB probe works specif-
ically at only one optimized annealing temperature (63C),
whereas the iDDS provides similar single-base discrimination
over a 23Crange (63C to40C).Noother qPCRprobe system
exhibits this capacity for consistent single-base discrimination
over a wide range of annealing temperatures. Moreover, this
ﬂexibility eases the design of multiplex iDDS assays because
different probes can be run together even if their predicted Tms
differ signiﬁcantly (Figures 5D and 7D).
iDDS and ZIPR probe performance may be predicted by
simulated hybridization testing (Figure 1C).6,7 In general,
single-base discrimination is achievable when stepwise
changes of about 5C to 5.5C in Tm and about 2.2 to 2.7
kcal/mol in DG are predicted when going from probe-to-
correct target hybridization to probeeto-antiprobe hybridi-
zation, and ﬁnally to probe-to-off-target hybridization. This
process is easily ﬁne-tuned for optimal Tm and DG differ-
ences by systematic base substitutions in the antiprobe. These
thermodynamics thus provide an overall Tm window of 10C
or more between the three afﬁnity levels. In some cases, it is
necessary to introduce a mismatch into the probe to achieve
the 10C Tm difference. Such intentional probe mismatches are
positioned two bases either upstream or downstream of the
targeted mutation, such that probe-to-off-target hybridization is
greatly destabilized through the formation of a 3-base hybrid-
ization bubble.7 Differences in Tm resulting from mismatches
are position dependent, with internal mismatches being more
destabilizing than terminal mismatches.26 Thus, probes are
typically designed with the targeted mutation or SNP located
within two or three bases from the probe center, whereas the
antiprobe mismatch is positioned three to seven bases from
either the 50 or 30 end.
While the antiprobe of ZIPR probes increases speciﬁcity
compared with standard primers or other primereprobe sys-
tems (Sunrise, Scorpion probes), they still have a small636potential for false-positive results. Nonetheless, they serve as
effective reference probes when used in conjunction with
iDDS probes. In such cases, the reference probe detects gene/
amplicon frequency, and the internal probe detects the relative
mutant frequency. With this approach (Figure 5, DeF), we
have positively detected the presence of variably sized trans-
forming EGFR deletion mutants27,28 that cannot be detected
with single-probe methods. Alternatively, the G-Force probejmd.amjpathol.org - The Journal of Molecular Diagnostics
DDS Probes for Advanced qPCR Detectioncan serve in a capacity similar to that of a low-cost reference
probe (Figure 7, B and D).
The DDS probe systems that use generic components
(MacMan, Universal, and Half-Universal probes) provide sig-
niﬁcant cost advantages because the labeled generic compo-
nents can be made in bulk (Figures 3 and 6). However, these
systems also facilitate assay optimization because they lower the
cost of testing multiple alternative targets. For example, when
developing an assay to detect avian inﬂuenza (Figure 6E),
primer design programs such as Primer329 were inadequate for
selecting potential primers that target conserved sites. However,
because Universal probes and antiprobes can be used with any
linker-extended primer, a shotgun targeting approach could be
used to quickly screen 30 potential primer pairs to identify the
most efﬁcient sets. Similarly, these low-cost assays enable
multitarget diagnostics, an approach that can reduce both false-
negatives and false-positives. Because Half-Universal probes
use one generic component, they allow only partial cost
reduction. However, they also provide quicker one-step detec-
tion and have less potential for cross-reaction. G-Force probes
also offer cost savings because they obviate a quencher label by
exploiting the natural ability of guanines to quench a ﬂuo-
rophore such as FAM.
Collectively, these data illustrate the potential of DDS tech-
nologies to provide highly speciﬁc and sensitive detection
comparedwith standard qPCRprobes. Routine diagnosticsmay
also beneﬁt from the use of lower-cost generic probes and
antiprobes for assay optimization or for easy targets. In contrast,
the detection of SNPs, somatic mutations, and drug-resistant
variants can be better servedwith iDDSor Flip probes versus the
standard probes. We also project the use of iDDS, ZIPR, and
Universal probes for validating SNP or gene fusion discoveries
from next-generation sequencing or array technologies.30
Finally, combining primereprobes with iDDS or Flip probes
can facilitate the analysis of mutant variants by providing
signature proﬁles that indicate mutant frequency. Further pub-
lications will document additional applications for DDS probes
as well as clinical validation studies that are currently in
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